Profil
Gegenwärtig ist Craig Paterson Chief Medical Officer bei Allakos, Inc. In der Vergangenheit war er Chief Medical Officer bei Endo International Plc und Senior VP-Medical & Clinical Development bei Salix Pharmaceuticals Ltd. Er erwarb einen Hochschulabschluss an der McMaster University und einen MBA an der University of Tennessee.
Ehemalige bekannte Positionen von Craig Paterson
| Unternehmen | Position | Ende |
|---|---|---|
| ALLAKOS INC. | Technik-/Wissenschafts-/F&E-Leiter | 09.02.2024 |
UMass Chan Medical School
UMass Chan Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Vivelix Pharmaceuticalsc Corp. | Gründer | - |
| ENDO INTERNATIONAL PLC | Technik-/Wissenschafts-/F&E-Leiter | - |
| SALIX PHARMACEUTICALS, LTD. | Corporate Officer/Principal | - |
Ausbildung von Craig Paterson
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Salix Pharmaceuticals Ltd.
Salix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops prescription drugs | Health Technology |
Endo International Plc
Endo International Plc Pharmaceuticals: MajorHealth Technology Develops and manufactures immunology, urology, hepatology, generics & sterile injectables therapeutics products | Health Technology |
McMaster University
McMaster University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Tennessee
University of Tennessee Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UMass Chan Medical School
UMass Chan Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Allakos, Inc.
Allakos, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company that develops innovative therapeutics which target immunomodulatory receptors for the treatment of allergic, inflammatory and proliferative diseases | Health Technology |
Vivelix Pharmaceuticalsc Corp. |
















